What the study found
The study found that critically ill patients who joined a COVID-19 clinical trial in Japan often had poor understanding of the trial details. Some participants were not aware they had consented to take part.
Why the authors say this matters
The authors conclude that informed consent for critically ill patients during health emergencies needs improvement. They suggest future research should help optimize consent and ongoing patient support to balance autonomy and public health needs.
What the researchers tested
The researchers used a qualitative method called conventional content analysis. They interviewed 10 participants from the anticoagulation domain of REMAP-CAP, an international randomized trial for COVID-19 treatments, all of whom had been hospitalized in a Japanese intensive care unit, judged competent, and given prospective informed consent.
What worked and what didn't
Three main categories were identified: participation without awareness or adequate understanding, interpretation of participation through personal circumstances, and emotions and thoughts evoked by participation. Details of the trial or interventions were poorly understood, and some participants were unaware they had consented; some were interested in future trials, while others remained uncertain about their experience.
What to keep in mind
The report is based on 10 participants from one trial domain in Japan, so the findings are limited to this group. The abstract does not describe additional limitations beyond the study’s small qualitative sample.
Key points
- Ten critically ill COVID-19 trial participants in Japan were interviewed.
- Many participants had poor understanding of the trial details.
- Some participants did not realize they had consented to join the study.
- The study identified mixed feelings about participation, including uncertainty and interest in future trials.
- The authors say informed consent and ongoing support should be improved in health emergencies.
Disclosure
- Research title:
- Critically ill COVID-19 trial participants often did not understand consent details
- Authors:
- Yumiko Oyama, Hiroki Saito, Yuiko Hoshina, Naoaki Ichihara, Kazuaki Jindai
- Institutions:
- Osaka Medical and Pharmaceutical University, St. Marianna University School of Medicine, St. Marianna University School of Medicine, Systems, Applications & Products in Data Processing (Canada), Tohoku University, Yokohama City Seibu Hospital
- Publication date:
- 2026-02-23
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with scholarly research without reading academic papers — one filtered digest, every Friday.